Liberate Medical, LLC to present at the Digital Medicine and Medtech Showcase™ Annual Conference on January 10, 2018

Crestwood, KY, Jan. 04, 2018 – Liberate Medical, LLC, a clinical stage medical device company developing neuromuscular electrical stimulation devices to improve care for patients with pulmonary disorders, today announced that its CEO, Angus McLachlan, will present at the Digital Medicine and Medtech Showcase ™ 2018 on Wednesday, January 10, 2018 at 1.15 p.m. (PST) at the Hilton San Francisco Union Square.

The Digital Medicine and Medtech Showcase™, produced by Demy-Colton and EBD Group, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences, J.P. Morgan Annual Healthcare Conference.

About Liberate

Liberate Medical develops neuromuscular electrical stimulation devices to improve the quality and reduce the cost of care for patients with pulmonary disorders. Its proprietary technology uses electrical muscle stimulation to activate the expiratory muscles in synchrony with exhalation, and is being developed to prevent breathing muscle atrophy in patients who are difficult to wean from mechanical ventilation (VentFree™ muscle stimulator), and to reduce shortness of breathing in patients with chronic obstructive pulmonary disorders (SecondBreath™ muscle stimulator).